跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
M-BETAHISTINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
M-BETAHISTINE
Authorized
STANDARD
M-BETAHISTINE
mantra pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
264985a14d26975c
Company
mantra pharma inc
Type
Standard
Approval Details
Approval Id
264985a14d26975c
Drug Approval Canada Name
M-BETAHISTINE
Product Name
M-BETAHISTINE
Status
Marketed
Status Date
2022-07-27
Original Market Date
2022-07-27
Din
02519682
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
92:00.00
Atc Original
N07CA01 BETAHISTINE
Atc Name
n 07 ca 01
Aig Number
0103555002
Company Name
mantra pharma inc
Company Address
1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3
Active Ingredients
BETAHISTINE HYDROCHLORIDE
8 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
264985a14d26975c
Type
Standard
Back to Health Canada Approvals